Literature DB >> 12527891

Protein kinase CK2 regulates CDC25B phosphatase activity.

Nathalie Theis-Febvre1, Odile Filhol, Carine Froment, Martine Cazales, Claude Cochet, Bernard Monsarrat, Bernard Ducommun, Véronique Baldin.   

Abstract

Human dual-specificity phosphatases CDC25 (A, B and C) play an important role in the control of cell cycle progression by activating the cyclin-dependent kinases (CDKs). Regulation of these phosphatases during the cell cycle involves post-translational modifications such as phosphorylation and protein-protein interactions. Given the suspected involvement of the protein kinase CK2 at the G2/M transition, we have investigated its effects on the CDC25B phosphatase. We show that in vitro CK2 phosphorylates CDC25B, but not CDC25C. Mass spectrometry analysis demonstrates that at least two serine residues, Ser-186 and Ser-187, are phosphorylated in vivo. We also report that CDC25B interacts with CK2, and this interaction, mediated by the CK2beta regulatory subunit, involves domains that are located within the first 55 amino acids of CK2beta and between amino acids 122 and 200 on CDC25B. This association was confirmed in vivo, in Sf9 insect cells and in U(2)OS human cells expressing an HA epitope-tagged CDC25B. Finally, we demonstrate that phosphorylation of CDC25B by protein kinase CK2 increases the catalytic activity of the phosphatase in vitro as well as in vivo. We discuss the possibility that CDC25B phosphorylation by CK2 could play a role in the regulation of the activity of CDC25B as a starter of mitosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527891     DOI: 10.1038/sj.onc.1206107

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  FW2.2 and cell cycle control in developing tomato fruit: a possible example of gene co-option in the evolution of a novel organ.

Authors:  Bin Cong; Steven D Tanksley
Journal:  Plant Mol Biol       Date:  2006-08-29       Impact factor: 4.076

2.  Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.

Authors:  Carolin C Schneider; Claudia Götz; Andrea Hessenauer; Jürgen Günther; Sabine Kartarius; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

3.  A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking.

Authors:  Véronique Baldin; Muriel Militello; Yann Thomas; Christine Doucet; Weronika Fic; Stephanie Boireau; Isabelle Jariel-Encontre; Marc Piechaczyk; Edouard Bertrand; Jamal Tazi; Olivier Coux
Journal:  Mol Biol Cell       Date:  2008-02-06       Impact factor: 4.138

4.  A role for CK2alpha/beta in Xenopus early embryonic development.

Authors:  Isabel Dominguez; Junko Mizuno; Hao Wu; Gregory A Imbrie; Karen Symes; David C Seldin
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

5.  Quantitative phosphoproteomics reveals new roles for the protein phosphatase PP6 in mitotic cells.

Authors:  Scott F Rusin; Kate A Schlosser; Mark E Adamo; Arminja N Kettenbach
Journal:  Sci Signal       Date:  2015-10-13       Impact factor: 8.192

6.  Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.

Authors:  Béatrice Laudet; Caroline Barette; Vincent Dulery; Olivier Renaudet; Pascal Dumy; Alexandra Metz; Renaud Prudent; Alexandre Deshiere; Otto Dideberg; Odile Filhol; Claude Cochet
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

7.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

Review 8.  Mechanism targeted discovery of antitumor marine natural products.

Authors:  Dale G Nagle; Yu-Dong Zhou; Flor D Mora; Kaleem A Mohammed; Yong-Pil Kim
Journal:  Curr Med Chem       Date:  2004-07       Impact factor: 4.530

9.  A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25.

Authors:  Odile Mondesert; Matthieu Lemaire; Marie-Christine Brezak; Marie Odile Galera-Contour; Grégoire Prevost; Bernard Ducommun; Béatrix Bugler
Journal:  Curr Genet       Date:  2004-01-15       Impact factor: 3.886

10.  An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing glioblastoma cells.

Authors:  Brian A Joughin; Kristen M Naegle; Paul H Huang; Michael B Yaffe; Douglas A Lauffenburger; Forest M White
Journal:  Mol Biosyst       Date:  2008-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.